CN111675632B - 一种可视化成像检测基因毒素Colibactin荧光分子探针及其制备方法和应用 - Google Patents
一种可视化成像检测基因毒素Colibactin荧光分子探针及其制备方法和应用 Download PDFInfo
- Publication number
- CN111675632B CN111675632B CN202010563510.5A CN202010563510A CN111675632B CN 111675632 B CN111675632 B CN 111675632B CN 202010563510 A CN202010563510 A CN 202010563510A CN 111675632 B CN111675632 B CN 111675632B
- Authority
- CN
- China
- Prior art keywords
- molecular probe
- crude product
- colibactin
- raw material
- probe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003068 molecular probe Substances 0.000 title claims abstract description 31
- ZWKHDAZPVITMAI-ROUUACIJSA-N colibactin Chemical compound C[C@H]1CCC(=N1)C1=C(CC(=O)NCC(=O)c2csc(n2)C(=O)C(=O)c2csc(CNC(=O)CC3=C(C(=O)NC33CC3)C3=N[C@@H](C)CC3)n2)C2(CC2)NC1=O ZWKHDAZPVITMAI-ROUUACIJSA-N 0.000 title claims abstract description 23
- 108010004171 colibactin Proteins 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 238000003384 imaging method Methods 0.000 title claims abstract description 16
- 230000000007 visual effect Effects 0.000 title claims abstract description 15
- 238000001514 detection method Methods 0.000 title abstract description 10
- 231100000446 genotoxin Toxicity 0.000 title abstract description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 57
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 36
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 23
- 239000012043 crude product Substances 0.000 claims description 20
- 239000012074 organic phase Substances 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 17
- 239000002994 raw material Substances 0.000 claims description 15
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 12
- 238000004440 column chromatography Methods 0.000 claims description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 239000011541 reaction mixture Substances 0.000 claims description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene chloride Substances ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 8
- 238000010791 quenching Methods 0.000 claims description 8
- 238000002390 rotary evaporation Methods 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 claims description 6
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 6
- 235000021360 Myristic acid Nutrition 0.000 claims description 6
- 229910003074 TiCl4 Inorganic materials 0.000 claims description 6
- 229910052681 coesite Inorganic materials 0.000 claims description 6
- 229910052906 cristobalite Inorganic materials 0.000 claims description 6
- -1 hexafluorophosphate Chemical compound 0.000 claims description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000377 silicon dioxide Substances 0.000 claims description 6
- 229910052682 stishovite Inorganic materials 0.000 claims description 6
- 229910052905 tridymite Inorganic materials 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 230000003197 catalytic effect Effects 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 239000007858 starting material Substances 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- YRMKKKHMOKEYJO-ONEGZZNKSA-N 2-[3-[(E)-2-(4-aminophenyl)ethenyl]-5,5-dimethylcyclohex-2-en-1-yl]propanedinitrile Chemical compound NC1=CC=C(/C=C/C2=CC(CC(C2)(C)C)C(C#N)C#N)C=C1 YRMKKKHMOKEYJO-ONEGZZNKSA-N 0.000 claims description 3
- FYYSQDHBALBGHX-UHFFFAOYSA-N 4-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxobutanoic acid Chemical compound CC(C)(C)OC(=O)NC(C(O)=O)CC(N)=O FYYSQDHBALBGHX-UHFFFAOYSA-N 0.000 claims description 3
- 239000007832 Na2SO4 Substances 0.000 claims description 3
- 239000012964 benzotriazole Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims description 3
- DDQHXORGIGZETN-HXSVJQCRSA-N CCCCCCCCCCCCCC(N[C@@H](CC#N)C(NC1=CC=C(/C=C/C(CC(C)(C)C2)=CC2=C(C#N)C#N)C=C1)=O)=O Chemical compound CCCCCCCCCCCCCC(N[C@@H](CC#N)C(NC1=CC=C(/C=C/C(CC(C)(C)C2)=CC2=C(C#N)C#N)C=C1)=O)=O DDQHXORGIGZETN-HXSVJQCRSA-N 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 230000000171 quenching effect Effects 0.000 claims description 2
- 239000000741 silica gel Substances 0.000 claims description 2
- 229910002027 silica gel Inorganic materials 0.000 claims description 2
- 241000672609 Escherichia coli BL21 Species 0.000 claims 1
- 239000000523 sample Substances 0.000 abstract description 17
- 241000894006 Bacteria Species 0.000 abstract description 8
- 241000588724 Escherichia coli Species 0.000 abstract description 5
- 239000007850 fluorescent dye Substances 0.000 abstract description 4
- 150000002500 ions Chemical class 0.000 abstract description 3
- 150000003384 small molecules Chemical class 0.000 abstract description 3
- 238000010226 confocal imaging Methods 0.000 abstract description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000002189 fluorescence spectrum Methods 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 239000006166 lysate Substances 0.000 description 4
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical class [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- 239000007821 HATU Substances 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
- 229930182846 D-asparagine Natural products 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- MXXAIQAMLFICNM-LFHMGQAQSA-N (2S)-N-[4-[(E)-2-[3-(dicyanomethylidene)-5,5-dimethylcyclohexen-1-yl]ethenyl]phenyl]-2-(tetradecanoylamino)butanediamide Chemical compound CCCCCCCCCCCCCC(=O)N[C@@H](CC(=O)N)C(=O)NC1=CC=C(C=C1)/C=C/C2=CC(=C(C#N)C#N)CC(C2)(C)C MXXAIQAMLFICNM-LFHMGQAQSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- 102000012440 Acetylcholinesterase Human genes 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 108010000659 Choline oxidase Proteins 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6402—Atomic fluorescence; Laser induced fluorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Materials Engineering (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了一种可视化成像检测基因毒素Colibactin荧光分子探针及其制备方法和应用,该探针的结构式如(1)所示:
Description
技术领域
本发明属于生物化学技术领域,具体涉及一种可视化成像检测基因毒素Colibactin荧光分子探针的制备方法和应用。
背景技术
肠道菌群作为人体肠道的正常微生物菌群,能合成多种人体生长发育必须的维生素,能利用蛋白质残渣合成必需氨基酸,并参与糖类和蛋白质的代谢,同时还能促进铁、镁、锌等矿物元素的吸收。另一方面,肠道菌群也作为肿瘤微环境的一部分,参与大部分消化道恶性肿瘤的发生、发展。研究表明,大肠杆菌中产生的一种名为Colibactin的基因毒素可通过破坏肠上皮细胞的DNA而导致肿瘤,从而大大增加了结直肠癌的发病率(Science, 2006,313(5788):848-851;Science,2018,359(6375):592-597)。因此,对Colibactin进行检测对结直肠癌的相关研究具有重要意义和实际价值。
由于Colibactin的结构复杂,迄今为止,尚无办法纯化Colibactin和确定其确切的结构,结果导致了其检测受到诸多限制。另一方面,参与Colibactin生物合成的肽酶ClbP是稳定存在的,其通过水解联接有保护基团N-肉豆蔻酰基D-天冬酰胺且无生物活性的Colibactin前体化合物而最终生产产生Colibactin(Journal of the American ChemicalSociety, 2013,135(9):3359-3362)。因此,通过ClbP能催化水解N-肉豆蔻酰基D-天冬酰胺的特性并结合“前药策略”建立一种灵敏、简单、选择性好的方法对ClbP进行检测或者在线监测,从而实现Colibactin的快速检测及其相关的研究是可行的。
发明内容
本发明旨在提供一种具有选择性好、灵敏度高、响应速度快的可视化成像检测基因毒素Colibactin的荧光分子探针的制备方法和应用。
为实现上述目的,本发明采用以下技术方案:
一种可视化成像检测基因毒素Colibactin荧光分子探针,其特征在于,所述分子探针具有如下化学结构式:
本发明还提供了所述荧光分子探针在制备基因毒素Colibactin及其上游肽酶ClbP检测试剂中的应用。
优选的,所述检测试剂是将荧光分子探针溶解到混合溶剂中制备得到的检测试剂,所述混合溶剂是体积比N,N-二甲基甲酰胺:4-(2-羟乙基)-1-哌嗪乙磺酸=2:(7-9)的混合溶剂。
优选的,所述检测试剂中荧光分子探针的浓度为4-6μM。进一步优先的浓度为5μM。
本发明还提供了所述荧光分子探针在制备可视化成像试剂中的应用,所述可视化成像试剂包括活体、组织、细胞和细菌的可视化成像试剂。
本发明还提供了所述可视化成像检测基因毒素Colibactin荧光分子探针的制备方法,所述荧光分子探针的制备方法包括以下步骤:
(1)原料a:N-Boc-D-天冬酰胺,原料b:(E)-2-(3-(4-氨基苯乙烯基)-5,5-二甲基环己-2-烯-1-基)丙二腈,原料c:2-(7-氧化苯并三氮唑)-N,N,N',N'-四甲基脲六氟磷酸盐和催化量的4-二甲氨基吡啶在无水吡啶溶液在室温下搅拌6-8小时,通过加入饱和碳酸氢钠水溶液淬灭反应混合物后用乙酸乙酯萃取,将合并的萃取液干燥并真空浓缩,得到粗品,纯化粗产物,得到中间体1:叔丁基(S,E)-(3-氰基-1-((4-(2-(3-(二氰基亚甲基) -5,5-二甲基环己-1-烯-1-基)乙烯基)苯基)氨基)-1-氧丙烷-2-基)氨基甲酸酯;
(2)将中间体1溶于CH2Cl2和三氟乙酸中,室温搅拌0.5-3h,加水除去三氟乙酸用乙酸乙酯萃取,有机相再用大量水洗,将有机相减压旋蒸除去后通过SiO2硅胶柱纯化,提纯时间为1-6小时,得到中间体2:(S,E)-2-氨基-3-氰基-N-(4-(2-(3-(二氰基亚甲基) -5,5-二甲基环己-1-烯-1-基)乙烯基)苯基)丙酰胺;
(3)将中间体2、肉豆蔻酸和原料c在吡啶中的溶液在室温搅拌5-7小时,停止反应后将反应液倒入大量饱和碳酸氢钠水溶液中有固体产生,抽滤后滤渣用乙酸乙酯溶解用Na2SO4干燥并真空浓缩,得到粗品,通过SiO2柱色谱纯化粗产物,得中间体3:(S,E) -N-(3-氰基-1-((4-(2-(3-(二氰基亚甲基)-5,5-二甲基环己-1-烯-1-基)乙烯基)苯基)氨基)-1-氧丙烷-2-基)十四烷酰胺;
(4)将中间体3溶于乙酸中,加入TiCl4和H2O,在室温下搅拌1-3小时,通入饱和碳酸氢钠水溶液淬灭反应混合物后用乙酸乙酯萃取,将合并的萃取液干燥并真空浓缩,得到粗品,纯化粗产物,得到荧光分子探针(S,E)-N1-(4-(2-(3-(二氰基亚甲基)-5,5-二甲基环己-1-烯-1-基)乙烯基)苯基)-2-十四碳酰胺基琥珀酰胺。
优选的,步骤(1)中原料a:原料b:原料c的摩尔比为:2:(1~3):(1~6);所述催化量的4-二甲氨基吡啶为10mg-100mg。
优选的,步骤(2)中CH2Cl2和三氟乙酸中的体积比为1:(1~2),进一步优选的方案为1:(0.8-1.2)。中间体1的摩尔质量与该混合溶剂的体积比为:1mM:(10~12mL)。反应时间进一步优选为为0.8-1.2h,提纯时间优选为1-3h。
优选的,步骤(3)中中间体2与肉豆蔻酸和原料c的摩尔比为:中间体2:肉豆蔻酸:原料c=1:(1~3):(1~6)。进一步优选的,步骤(3)中中间体2与肉豆蔻酸和原料c的摩尔比为:中间体2:肉豆蔻酸:原料c=1:(1~2):(3~5)。
优选的,步骤(4)将中间体3溶于5mL-20mL乙酸中,加入TiCl4和20μL-200μLH2O,其中中间体3与TiCl4的摩尔比值为1:(1.2~5)。进一步优选的,中间体3与TiCl4的摩尔比为1:(2~3)。
说明书中所述的室温是20℃-30℃。
本发明的检测基因毒素Colibactin荧光分子探针具有选择性好、灵敏度高、响应速度快等特点,并且由于发射处于近红外区域,可避免生物自发荧光的干扰,能良好的应用于生物体内基因毒素Colibactin的可视化成像分析。
附图说明
图1为本发明的荧光分子探针的合成示意图;
图2为本发明的荧光分子探针的核磁共振氢谱;
图3为本发明的荧光分子探针加入目标细菌裂解液后的荧光光谱变化图;
图4为本发明的荧光分子探针对不同细菌裂解液的检测选择性图,图中横坐标数字 1-8代表的物质如下:1.大肠杆菌(BL21),2.鼠伤寒沙门氏菌,3.甲型副伤寒沙门氏菌,4.铜绿假单胞菌,5.金黄色葡萄球菌,6.大肠杆菌(K88),7.肠炎沙门氏菌,8.猪霍乱沙门氏菌;
图5为本发明的荧光分子探针对常见小分子(A)、离子的选择性图(B),(A)图横坐标数字1-28代表的物质如下:1.ClbP,2.K+,3.Na+,4.Mn2+,5.Fe3+,6.Ba2+,7.Cu2+,8. Zn2+,9.Al3+,10.Cd2+,11.Co2+,12.Mg2+,13.NH4 +,14.F-,15.Cl-,16.Br-,17.I-,18.NO3 -,19. NO2 -,20.S2O3 -,21.SO3 2-,22.SO4 2-,23.HCO3 -,24.CO3 2-,25.N3 -,26.HSO3 -,27.S2-,28. CH3COO-.
(B)图横坐标数字1-30代表的物质如下:1.ClbP,2.甘氨酸Gly,3.组氨酸His,4.甲硫氨酸Met,5.天冬氨酸Asp,6.苏氨酸Thr,7.赖氨酸Lys,8.酪氨酸Try,9.谷氨酸Glu, 10.半胱氨酸Cys,11.同型半胱氨酸Hcy,12.谷胱甘肽GSH,13.ClO-,14.叔丁基过氧化氢TBHP,15.1O2,16.ONOO-,17.·OH,18.氧叔丁基·OtBu,19.O2 -,20.尿素urea,21.H2O2, 22.酸性磷酸酶ACP,23.胆碱氧化酶ChOD,24.β-半乳糖苷酶β-Gal,25.磷酸二酯酶 PDE,26.胰蛋白酶Trypsin,27.辣根过氧化物酶HRP,28.葡萄糖氧化酶GOD,29.乙酰胆碱酯酶AchE,30.碱性磷酸酶ALP;
图6为本发明的荧光分子探针对目标细菌的荧光共聚焦成像图。
具体实施方式
以下将结合附图和具体实施例来进一步阐述本发明。这些实施例仅用于解释和说明本发明,而并非限制本发明的范围。
名称符号解释:
HATU:2-(7-氧化苯并三氮唑)-N,N,N',N'-四甲基脲六氟磷酸盐;
DMAP:4-二甲氨基吡啶;
HEPES:4-(2-羟乙基)-1-哌嗪乙磺酸
实施例1:中间体1的制备
(1)N-Boc-D-天冬酰胺(140mg,600μmol),(E)-2-(3-(4-氨基苯乙烯基)-5,5- 二甲基环己-2-烯-1-基)丙二腈(127mg,300μmol),HATU(457mg,1.2mmol)和催化量的4-二甲氨基吡啶(30mg,250μmol)在无水吡啶(0.5mL)溶液在25℃下搅拌7 小时。通过加入饱和碳酸氢钠水溶液(10mL)淬灭反应混合物。用乙酸乙酯(10mL×3) 萃取所得混合物。将合并的萃取液用Na2SO4干燥并真空浓缩,得到粗品。通过SiO2柱色谱纯化粗产物,得到中间体1,产率为54%。
实施例2:中间体2的制备
中间体1(291mg,600μmol)溶于3mL CH2Cl2和3mL三氟乙酸中。25℃搅拌1h,加水除去三氟乙酸用乙酸乙酯萃取,有机相再用大量水洗,将有机相减压旋蒸除去后快速通过柱层析方法提纯,时间为2小时。得到中间体2,产率为67%。
实施例3:中间体2的制备
中间体1(291mg,600μmol)溶于3mL CH2Cl2和3mL三氟乙酸中。25℃搅拌4h,加水除去三氟乙酸用乙酸乙酯萃取,有机相再用大量水洗,将有机相减压旋蒸除去后快速通过柱层析方法提纯,时间为2小时。没有得到目标产率,可能由于反应时间过长导致目标产物分解。
实施例4:中间体2的制备
中间体1(291mg,600μmol)溶于3mL CH2Cl2和6mL三氟乙酸中。25℃搅拌1h,加水除去三氟乙酸用乙酸乙酯萃取,有机相再用大量水洗,将有机相减压旋蒸除去后快速通过柱层析方法提纯,时间为2小时。得到中间体2,产率为20%。
实施例5:中间体2的制备
中间体1(291mg,600μmol)溶于6mL CH2Cl2和3mL三氟乙酸中。25℃搅拌1h,加水除去三氟乙酸用乙酸乙酯萃取,有机相再用大量水洗,将有机相减压旋蒸除去后快速通过柱层析方法提纯,时间为2小时。得到中间体2,产率为25%。
实施例6:中间体2的制备
中间体1(291mg,600μmol)溶于3mL CH2Cl2和3mL三氟乙酸中。25℃搅拌1h,加水除去三氟乙酸用乙酸乙酯萃取,有机相再用大量水洗,将有机相减压旋蒸除去后通过柱层析方法提纯,时间为6小时。得到中间体2,产率为30%。
实施例7:中间体3的制备
将中间体2(231mg,600μmol)、肉豆蔻酸(205mg,900μmol)和HATU(608mg,1.6mmol)在吡啶(5mL)中的溶液在25℃搅拌6小时。停止反应后将反应液倒入大量饱和碳酸氢钠水溶液中有固体产生,抽滤后滤渣用乙酸乙酯溶解用Na2SO4干燥并真空浓缩,得到粗品。通过SiO2柱色谱纯化粗产物,得到中间体3,产率为43%。
实施例8:探针的制备
将中间体3(595mg,1mmol)溶于5mL乙酸中,加入TiCl4(187mg,1mmol)和 50μL H2O。在25℃下搅拌2小时,通入饱和碳酸氢钠水溶液淬灭反应混合物后用乙酸乙酯萃取,将合并的萃取液干燥并真空浓缩,得到粗品,通过柱层析方法纯化粗产物,得到荧光分子探针,产率为43%。
实施例9:探针的制备
将中间体3(595mg,1mmol)溶于5mL乙酸中,加入TiCl4(374mg,2mmol)和 50μL H2O。在25℃下搅拌2小时,通入饱和碳酸氢钠水溶液淬灭反应混合物后用乙酸乙酯萃取,将合并的萃取液干燥并真空浓缩,得到粗品,通过柱层析方法纯化粗产物,得到荧光分子探针,产率为68%。
实施例10:探针的制备
将中间体3(595mg,1mmol)溶于5mL乙酸中,加入TiCl4(561mg,3mmol)和 50μL H2O。在25℃下搅拌2小时,通入饱和碳酸氢钠水溶液淬灭反应混合物后用乙酸乙酯萃取,将合并的萃取液干燥并真空浓缩,得到粗品,通过柱层析方法纯化粗产物,得到荧光分子探针,产率为84%。
实施例11:探针的制备
将中间体3(595mg,1mmol)溶于5mL乙酸中,加入TiCl4(935mg,5mmol)和 50μL H2O。在25℃下搅拌2小时,通入饱和碳酸氢钠水溶液淬灭反应混合物后用乙酸乙酯萃取,将合并的萃取液干燥并真空浓缩,得到粗品,通过柱层析方法纯化粗产物,得到荧光分子探针,产率为53%。
实施例12
将该分子荧光探针溶于DMF中,配置成1mmol/L的探针溶液;取探针溶液加入相应的DMF和HEPES(pH=7.4)缓冲液,配置成10μM(有机相:HEPES水相=2:8,v/v) 的溶液,分别加入10μL,50μL,100μL和200μL有ClbP表达的细菌裂解液,37℃下孵育1h后,以470nm作为激发波长,测试其荧光光谱变化情况。图2表明探针分子在 660nm处的荧光强度随着ClbP含量的增加而增强。
实施例13:
将该分子荧光探针溶于DMF中,配置成1mmol/L的探针溶液;取探针溶液加入相应的DMF和HEPES(pH=7.4)缓冲液,配置成10μM(有机相:HEPES水相=2:8,v/v)的溶液,分别加入不同种类的细菌裂解液,37℃下孵育1h后,以470nm作为激发波长,测试其荧光光谱变化情况。图3表明探针对检测能表达ClbP的细菌具有很好的选择性。
实施例14:
将该分子荧光探针溶于DMF中,配置成1mmol/L的探针溶液;取探针溶液加入相应的DMF和HEPES(pH=7.4)缓冲液,配置成10μM(有机相:HEPES水相=2:8,v/v)的溶液,分别加入常见小分子、离子,37℃下孵育1h后,以470nm作为激发波长,测试其荧光光谱变化情况。图4表明探针对检测能表达ClbP的细菌具有很好的选择性。
实施例15:
将该分子探针加入到细胞培养基中与能表达ClbP的细菌共培养2小时,随后进行荧光共聚焦成像。图5可以看出,加入本探针的细菌呈现出红色荧光,表明本探针可以用于细菌成像鉴定。
尽管本发明的内容已经通过上述优选实施例作了详细的介绍,但应当认识到上述的描述不应被认为是对本发明的限制。在本领域技术人员阅读了上述内容后,对于本发明的多种修改和替代都将是显而易见的。因此,本发明的保护范围因由所附的权利要求来限定。
Claims (5)
2.权利要求1所述应用,其特征是,所述荧光分子探针的制备方法包括以下步骤:
(1)原料a:N-Boc-D-天冬酰胺,原料b:(E)-2-(3-(4-氨基苯乙烯基)-5,5-二甲基环己-2-烯-1-基)丙二腈,原料c:2-(7-氧化苯并三氮唑)-N,N,N',N'-四甲基脲六氟磷酸盐和催化量的4-二甲氨基吡啶的 无水吡啶溶液在室温下搅拌6-8小时,通过加入饱和碳酸氢钠水溶液淬灭反应混合物后用乙酸乙酯萃取,将合并的萃取液干燥并真空浓缩,得到粗品,纯化粗产物,得到中间体1:叔丁基(S,E)-(3-氰基-1-((4-(2-(3-(二氰基亚甲基)-5,5-二甲基环己-1-烯-1-基)乙烯基)苯基)氨基)-1-氧丙烷-2-基)氨基甲酸酯;
(2)将中间体1溶于CH2Cl2和三氟乙酸中,室温搅拌0.5-3 h,加水除去三氟乙酸, 用乙酸乙酯萃取,有机相再用大量水洗,将有机相减压旋蒸除去后通过SiO2硅胶柱纯化,提纯时间为1-6小时,得到中间体2:(S,E)-2-氨基-3-氰基-N-(4-(2-(3-(二氰基亚甲基)-5,5-二甲基环己-1-烯-1-基)乙烯基)苯基)丙酰胺;
(3)将中间体2、肉豆蔻酸和原料c在吡啶中的溶液在室温搅拌5-7小时,停止反应后将反应液倒入大量饱和碳酸氢钠水溶液中有固体产生,抽滤后滤渣用乙酸乙酯溶解用Na2SO4干燥并真空浓缩,得到粗品,通过SiO2柱色谱纯化粗产物,得到中间体3:(S,E)-N-(3-氰基-1-((4-(2-(3-(二氰基亚甲基)-5,5-二甲基环己-1-烯-1-基)乙烯基)苯基)氨基)-1-氧丙烷-2-基)十四烷酰胺;
3.根据权利要求2所述应用,其特征在于,步骤(1)中原料a:原料b:原料c的摩尔比为:2:(1~3):(1~6);所述催化量的4-二甲氨基吡啶为10 mg-200 mg。
4.根据权利要求2所述应用,其特征在于,步骤(2)中CH2Cl2和三氟乙酸的体积比为1:(1-2)。
5.根据权利要求2所述应用,其特征在于,步骤(3)中中间体2与肉豆蔻酸和原料c的摩尔比为:中间体2:肉豆蔻酸:原料c=1:(1~3):(1~6)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010563510.5A CN111675632B (zh) | 2020-06-22 | 2020-06-22 | 一种可视化成像检测基因毒素Colibactin荧光分子探针及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010563510.5A CN111675632B (zh) | 2020-06-22 | 2020-06-22 | 一种可视化成像检测基因毒素Colibactin荧光分子探针及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111675632A CN111675632A (zh) | 2020-09-18 |
CN111675632B true CN111675632B (zh) | 2021-06-22 |
Family
ID=72436649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010563510.5A Active CN111675632B (zh) | 2020-06-22 | 2020-06-22 | 一种可视化成像检测基因毒素Colibactin荧光分子探针及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111675632B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114539275A (zh) * | 2020-11-26 | 2022-05-27 | 南京碳硅人工智能生物医药技术研究院有限公司 | 基于喜树碱对h2o2响应的荧光标记前药的设计与合成 |
CN115286534B (zh) * | 2022-04-26 | 2023-08-15 | 安徽工程大学 | 一种特异性检测Hg2+的近红外荧光化学传感器及其制备方法和应用 |
CN115490635A (zh) * | 2022-09-20 | 2022-12-20 | 湖南师范大学 | 一种可视化成像和在线监测携Clb毒素大肠杆菌荧光探针的合成及应用 |
CN115385868A (zh) * | 2022-10-10 | 2022-11-25 | 湖南师范大学 | 一种高选择性识别ClbP荧光探针的合成及应用 |
CN115490654A (zh) * | 2022-10-18 | 2022-12-20 | 湖南师范大学 | 一种检测携Clb毒素大肠杆菌荧光探针的合成与应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019044736A1 (ja) * | 2017-08-28 | 2019-03-07 | 静岡県公立大学法人 | コリバクチンおよびコリバクチン産生菌の検出方法および検出プローブ |
WO2020037009A8 (en) * | 2018-08-13 | 2020-03-26 | Flagship Pioneering Innovations V, Inc. | Conjugates and methods of using the same |
CN111303072A (zh) * | 2020-02-27 | 2020-06-19 | 山西大学 | 一种区分检测半胱氨酸的试剂及其合成方法和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602005023517D1 (de) * | 2004-11-24 | 2010-10-21 | Hoffmann La Roche | Verfahren zur bestimmung von genotoxizität |
CN107686479B (zh) * | 2017-09-30 | 2020-11-13 | 湖南师范大学 | 一种近红外荧光探针化合物及其制备方法和应用 |
US11040951B2 (en) * | 2018-08-17 | 2021-06-22 | President And Fellows Of Harvard College | Methods and compositions relating to genotoxin colibactin |
-
2020
- 2020-06-22 CN CN202010563510.5A patent/CN111675632B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019044736A1 (ja) * | 2017-08-28 | 2019-03-07 | 静岡県公立大学法人 | コリバクチンおよびコリバクチン産生菌の検出方法および検出プローブ |
WO2020037009A8 (en) * | 2018-08-13 | 2020-03-26 | Flagship Pioneering Innovations V, Inc. | Conjugates and methods of using the same |
CN111303072A (zh) * | 2020-02-27 | 2020-06-19 | 山西大学 | 一种区分检测半胱氨酸的试剂及其合成方法和应用 |
Non-Patent Citations (2)
Title |
---|
Activity-Based Probe for Screening of High-Colibactin Producers from Clinical Samples;Yuichiro Hirayama,等;《Organic Letters》;20190613;第21卷(第12期);第4490页左栏第2行,第4491页图1b、1c,第4490页摘要,第 4492页左栏第1-3行,supporting information第21-22页2.1节 * |
Near-Infrared Fluorescent Probe with Remarkable Large Stokes Shift and Favorable Water Solubility for Real-Time Tracking Leucine Aminopeptidase in Living Cells and In Vivo;Wenda Zhang,等;《Analytical Chemistry》;20171019;第89卷(第22期);摘要,第12321页图1a,第12321页图1b * |
Also Published As
Publication number | Publication date |
---|---|
CN111675632A (zh) | 2020-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111675632B (zh) | 一种可视化成像检测基因毒素Colibactin荧光分子探针及其制备方法和应用 | |
CN110746410B (zh) | 一种亮氨酸氨肽酶和单胺氧化酶激活的近红外荧光探针、合成方法及生物应用 | |
CN113999219B (zh) | 一种双位点荧光探针及其合成方法和应用 | |
CN109438326B (zh) | 一种用于检测羧酸酯酶的荧光探针及其制备方法与专用检测试剂盒 | |
CN109369719B (zh) | 一种用于碱性磷酸酶检测的分子探针及制备方法与应用 | |
CN110283583A (zh) | γ-谷氨酰转肽酶响应型分子探针及其应用 | |
CN109134371B (zh) | 荧光比率探针及其合成方法和检测细胞内溶酶体甲醛应用 | |
CN109705847B (zh) | 一种二氧化硫的比率荧光探针及其合成方法和应用 | |
CN113004220B (zh) | 一种酯酶检测荧光探针、制备方法及应用 | |
CN108752275B (zh) | 一种pH荧光探针及其制备方法和应用 | |
CN115650897A (zh) | 一种同时检测Cys和线粒体粘度的荧光探针及其制备方法和应用 | |
CN105884713A (zh) | 一种荧光增强型硫化氢分子荧光探针及其制备方法和应用 | |
CN108727265A (zh) | 一种检测甲醛和pH的双功能荧光探针及其制备方法和应用 | |
CN110105391B (zh) | 碱性磷酸酶响应型分子探针及其应用 | |
CN109485627B (zh) | 一种香豆素衍生物及其合成方法和在检测硫化氢中的应用 | |
CN115521324B (zh) | 一种检测耐药菌中β-内酰胺酶的近红外荧光探针的制备 | |
CN117024492A (zh) | 一种具有大斯托克斯位移的β-半乳糖苷酶近红外荧光探针及其制备方法与应用 | |
CN116535364A (zh) | 一种特异性识别亮氨酸氨基肽酶的荧光探针及制备方法和应用 | |
CN108424402B (zh) | γ-谷氨酰转肽酶生物探针及其制备方法和应用 | |
CN115819342B (zh) | 一种羧酸酯酶2荧光探针及其合成方法和应用 | |
CN111943923B (zh) | 一种香豆素衍生物及其制备方法和应用 | |
CN110746339B (zh) | 一种吡咯双腙衍生物荧光探针及其制备方法和应用 | |
CN113773302A (zh) | 一种喹啉类化合物及其制备方法与应用 | |
CN113788821A (zh) | 近红外联氨化合物、制备方法以及甲醛检测试剂盒和应用 | |
CN113980037A (zh) | 一种检测高半胱氨酸的比率型荧光探针的制备方法及其在细胞成像与生物传感中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |